Is Ligand Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: LGND) stock is to Strong Buy LGND stock.
Out of 3 analysts, 2 (66.67%) are recommending LGND as a Strong Buy, 1 (33.33%) are recommending LGND as a Buy, 0 (0%) are recommending LGND as a Hold, 0 (0%) are recommending LGND as a Sell, and 0 (0%) are recommending LGND as a Strong Sell.
What is LGND's forecast return on equity (ROE) for 2023-2024?
(NASDAQ: LGND) forecast ROE is N/A, which is considered weak.
What is LGND's Price Target?
According to 3 Wall Street analysts that have issued a 1 year LGND price target, the average LGND price target is $116.33, with the highest LGND stock price forecast at $144.00 and the lowest LGND stock price forecast at $95.00.
On average, Wall Street analysts predict that Ligand Pharmaceuticals's share price could reach $116.33 by Sep 19, 2024. The average Ligand Pharmaceuticals stock price prediction forecasts a potential upside of 96.91% from the current LGND share price of $59.08.
What is LGND's forecast return on assets (ROA) for 2023-2024?
(NASDAQ: LGND) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 1.55%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.